Company News
Wednesday preview: Davos, Burberry Group in focus
The focus around the world on Wednesday will continue to be on the World Economic Forum in Davos.
Sainsbury to axe 'hundreds' more management jobs - Sky
Sainsbury's will let go "hundreds" more managers as it continues to try and integrate Argos, which it purchased in 2016, into its own stores.
Integumen's Labskin inks deal with Innocare Group
Integumen announced on Tuesday that its subsidiary Labskin has signed a memorandum of understanding with Innocare Group.
Cambria buys Aston Martin and Rolls-Royce dealerships in Edinburgh
Franchised motor retailer Cambria Automobiles announced the acquisition of one Aston Martin franchise and one Rolls-Royce Motor Cars franchise in Edinburgh on Tuesday, from the administrator of Leven Cars Group.
Entertainment AI makes solid progress throughout 2019
Technology and media platform developer Entertainment AI said on Tuesday that both its motoring-focused Youtube channel and its Tagasauris artificial intelligence subsidiary had made some solid progress during 2019.
Uber offloads Indian food delivery business
Uber has struck a deal to sell its Indian food delivery service to local food app Zomato.
Hardide raises £2.5m in 'substantially oversubscribed' placing
Advanced surface coating technology company Hardide has conditionally raised £2. 5m before expenses by way of a placing, it announced on Tuesday.
Pennant buys out Aussie-based ADG
Training and support provider Pennant International Group has exchanged contracts to acquire Australia-based Absolute Data Group (ADG), it announced on Tuesday.
Citi downgrades 'fairly valued' Morgan Stanley
Citi has downgraded its rating on Morgan Stanley, arguing that the bank is already fairly valued.
Elecosoft 2019 results seen in line with market views
Construction software specialist Elecosoft said on Tuesday that results for the year to the end of December are expected to be ahead of the prior year and in line with market expectations despite "difficult" trading conditions.
Boeing approves Velocity Composites to supply 737 MAX programme
Advanced aerospace composite supplier Velocity Composites has received approval from Boeing to supply structural composite material kits for its single aisle narrowbody jet platform, it announced on Tuesday.
Dixons Carphone reports mixed performance over festive period
Dixons Carphone reported a rise in electricals revenue over the festive period but a drop in mobile sales on Tuesday as it said it was on course to deliver on its full-year expectations.
Aviva chairman Adrian Montague to retire
Insurer Aviva said on Tuesday that chairman Adrian Montague will retire this year once a successor has been appointed.
UBS shares slide despite solid end to the year
Shares in UBS fell on Tuesday, after the Swiss bank pulled back on its targets despite a strong finish to the year.
Black Friday timing partly to blame as Joules revenue declines
Clothing retailer Joules posted a decline interim revenue on Tuesday, pinning the blame partly on the timing of Black Friday.
Corero books record order intake during H2
Network security firm Corero booked a record order intake during the second half of 2019, alongside some strong recurring revenue growth and an order book pipeline that underpinned its outlook for 2020.
Camellia warns on profits following tea over-production
Agriculture and horticulture group Camellia cautioned on Tuesday that over-production of tea globally in 2018 was expected to weigh heavily on its results for 2019.
7digital surges following update on 'year of transformation'
Shares in digital music solutions provider 7digital surged on Tuesday morning after providing an update on its transformational trading year.
ADVFN warns on interim revenues; to cut headcount
Financial information provider ADVFN on Tuesday warned first-half sales were forecast to come in below expectations and it would be cutting jobs to reduce costs.
Roche gets conditional approval in Europe for lymphoma therapy
Roche announced on Tuesday that the European Commission has granted conditional marketing authorisation for ‘Polivy’ (polatuzumab vedotin), in combination with bendamustine plus ‘MabThera’ (rituximab), for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma who were not candidates for a haematopoietic stem cell transplant.